Skip to main content
. 2021 Jan 7;16(1):e0245077. doi: 10.1371/journal.pone.0245077

Fig 3. Signaling Lymphocyte Activating Molecule (SLAM) expression on T and B lymphocytes.

Fig 3

SLAM expression on CD4+, CD8+ T cells and CD19+ B cells of subacute sclerosing panencephalitis patients (SSPE, n = 44, n = 43 and n = 26), controls with inflammatory diseases (ICON, n = 35, n = 34 and n = 18) and with non-inflammatory diseases (NICON, n = 12 n = 13 and n = 9) are shown. Horizontal lines depict median values.